Consistently, immunohistochemical data from the HPA databases confirmed increased CTU2 protein levels in BRCA, COAD, LIHC, and lung adenocarcinoma (LUAD) (Figure 1F). The gene discussed is CTU2; the disease is lung adenocarcinoma.